1994 related articles for article (PubMed ID: 14755719)
1. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
[TBL] [Abstract][Full Text] [Related]
2. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
[TBL] [Abstract][Full Text] [Related]
3. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
Choi W; Zibaee S; Jakes R; Serpell LC; Davletov B; Crowther RA; Goedert M
FEBS Lett; 2004 Oct; 576(3):363-8. PubMed ID: 15498564
[TBL] [Abstract][Full Text] [Related]
4. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
5. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
6. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
7. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
[TBL] [Abstract][Full Text] [Related]
8. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH
Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897
[TBL] [Abstract][Full Text] [Related]
9. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
[TBL] [Abstract][Full Text] [Related]
10. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease.
Ishikawa A; Piao YS; Miyashita A; Kuwano R; Onodera O; Ohtake H; Suzuki M; Nishizawa M; Takahashi H
Ann Neurol; 2005 Mar; 57(3):429-34. PubMed ID: 15732120
[TBL] [Abstract][Full Text] [Related]
11. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.
Farrer M; Kachergus J; Forno L; Lincoln S; Wang DS; Hulihan M; Maraganore D; Gwinn-Hardy K; Wszolek Z; Dickson D; Langston JW
Ann Neurol; 2004 Feb; 55(2):174-9. PubMed ID: 14755720
[TBL] [Abstract][Full Text] [Related]
12. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
13. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of alpha-synuclein mutations in familial Parkinson's disease.
Farrer M; Wavrant-De Vrieze F; Crook R; Boles L; Perez-Tur J; Hardy J; Johnson WG; Steele J; Maraganore D; Gwinn K; Lynch T
Ann Neurol; 1998 Mar; 43(3):394-7. PubMed ID: 9506559
[TBL] [Abstract][Full Text] [Related]
17. [Lewy bodies, a misleading marker for Parkinson's disease?].
Duyckaerts C; Hauw JJ
Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
[TBL] [Abstract][Full Text] [Related]
18. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
19. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.
Ikeuchi T; Kakita A; Shiga A; Kasuga K; Kaneko H; Tan CF; Idezuka J; Wakabayashi K; Onodera O; Iwatsubo T; Nishizawa M; Takahashi H; Ishikawa A
Arch Neurol; 2008 Apr; 65(4):514-9. PubMed ID: 18413475
[TBL] [Abstract][Full Text] [Related]
20. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]